In addition, DCLK1 was shown to be overexpressed and deregulated in > 93% of RCC tumours, and its knockdown by siRNA in RCC cells resulted in decreased expression of EMT and cancer stem cell (CSC) markers [29]. This evidence concerns the gene DCLK1 and renal cell carcinoma.